BR9600487A - Utilização de ao menos um antagonistsa de cgrp utilização de ao menos um antagonista de cgrp em uma composição tópica processo de tratamento cosmético e composição - Google Patents

Utilização de ao menos um antagonistsa de cgrp utilização de ao menos um antagonista de cgrp em uma composição tópica processo de tratamento cosmético e composição

Info

Publication number
BR9600487A
BR9600487A BR9600487A BR9600487A BR9600487A BR 9600487 A BR9600487 A BR 9600487A BR 9600487 A BR9600487 A BR 9600487A BR 9600487 A BR9600487 A BR 9600487A BR 9600487 A BR9600487 A BR 9600487A
Authority
BR
Brazil
Prior art keywords
cgrp antagonist
composition
treatment process
cosmetic treatment
topical composition
Prior art date
Application number
BR9600487A
Other languages
English (en)
Inventor
Lionel Breton
Lacharriere Olivier De
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9475528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9600487(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oreal filed Critical Oreal
Publication of BR9600487A publication Critical patent/BR9600487A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9600487A 1995-01-26 1996-01-19 Utilização de ao menos um antagonistsa de cgrp utilização de ao menos um antagonista de cgrp em uma composição tópica processo de tratamento cosmético e composição BR9600487A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500900A FR2729855A1 (fr) 1995-01-26 1995-01-26 Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue

Publications (1)

Publication Number Publication Date
BR9600487A true BR9600487A (pt) 1998-03-03

Family

ID=9475528

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9600487A BR9600487A (pt) 1995-01-26 1996-01-19 Utilização de ao menos um antagonistsa de cgrp utilização de ao menos um antagonista de cgrp em uma composição tópica processo de tratamento cosmético e composição

Country Status (14)

Country Link
US (1) US6019967A (pt)
EP (1) EP0723774B1 (pt)
JP (1) JP3043608B2 (pt)
AR (1) AR002023A1 (pt)
AT (1) ATE197896T1 (pt)
BR (1) BR9600487A (pt)
CA (1) CA2167980C (pt)
DE (1) DE69611106T2 (pt)
DK (1) DK0723774T3 (pt)
ES (1) ES2154388T3 (pt)
FR (1) FR2729855A1 (pt)
HU (1) HUP9600162A3 (pt)
PL (1) PL184701B1 (pt)
RU (1) RU2180854C2 (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
MX9710479A (es) * 1995-09-07 1998-03-31 Oreal Extracto de iridaceas y composiciones que la contienen.
JP3483893B2 (ja) * 1996-09-10 2004-01-06 ドクトル カルル トーマエ ゲゼルシャフト ミット ベシュレンクテル ハフツング 修飾アミノ酸、これらの化合物を含む薬物及びそれらの調製方法
US6313097B1 (en) 1999-03-02 2001-11-06 Boehringer Ingelheim Pharma Kg Antagonists of calcitonin gene-related peptide
US7393548B2 (en) * 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
DE19952147A1 (de) 1999-10-29 2001-05-03 Boehringer Ingelheim Pharma Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE19958121A1 (de) * 1999-12-02 2001-06-28 Max Planck Gesellschaft Tyrosin- und tryptophanhaltige Peptide als Antioxidantien
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
WO2002026191A2 (en) * 2000-09-28 2002-04-04 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US7632522B2 (en) 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US6632420B1 (en) 2000-09-28 2003-10-14 The Gillette Company Personal care product
IL164191A0 (en) * 2002-03-26 2005-12-18 Nanocyte Inc Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosme tic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue nanocyte inc.
DK1556020T3 (da) * 2002-08-12 2009-06-22 Birkir Sveinsson Anvendelse af CGRP-antagonistforbindelser til behandling af psoriasis
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20040120915A1 (en) * 2002-12-19 2004-06-24 Kaiyuan Yang Multifunctional compositions for surface applications
EP1452167A1 (de) * 2003-02-28 2004-09-01 Cognis France S.A. Kosmetische, pharmazeutische und/oder dermatologische Zubereitungen enthaltend einen Extrakt aus Eperua falcata
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
JP2008540508A (ja) * 2005-05-09 2008-11-20 フォーミックス エルティーディー． 起泡性ビヒクル及びその医薬組成物
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
CN102525829B (zh) * 2006-03-07 2014-08-06 埃莱文斯可更新科学公司 含有复分解不饱和多元醇酯的组合物
CN101500608A (zh) 2006-06-08 2009-08-05 中外制药株式会社 炎性疾病的预防或治疗药
JP2010502690A (ja) * 2006-09-08 2010-01-28 フォーミックス エルティーディー． 有色または着色可能発泡性組成物
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP1986473B1 (en) * 2007-04-03 2017-01-25 Tsinghua University Organic electroluminescent device
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
ES2834741T3 (es) 2007-12-05 2021-06-18 Chugai Pharmaceutical Co Ltd Anticuerpo anti-NR10 y uso del mismo
CA2708065C (en) * 2007-12-05 2015-02-24 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for pruritus
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2009090558A2 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CN102686205A (zh) 2009-10-02 2012-09-19 弗艾米克斯有限公司 局部四环素组合物
FR3001391B1 (fr) * 2013-01-29 2017-07-07 Oreal Utilisation de cellules vegetales d'iridacee elicitees dans le traitement des peaux sensibles
BR112017022101A2 (pt) 2015-04-14 2018-07-31 Chugai Seiyaku Kabushiki Kaisha composição farmacêutica para prevenção e/ou tratamento de dermatite atópica contendo antagonista de il-31 como ingrediente ativo
MX2017011630A (es) 2016-09-08 2018-09-25 Foamix Pharmaceuticals Ltd Composiciones y metodos para tratar rosacea y acne.
US11433119B2 (en) * 2016-11-18 2022-09-06 Nepsone Ehf Methods of treating inflammatory skin disorders
GB2576208B (en) * 2018-08-10 2023-05-17 Exit Surf Street Summit Ltd Hanger for holding watersport garments
BR112022006590A2 (pt) 2019-11-20 2022-06-28 Chugai Pharmaceutical Co Ltd Preparação contendo anticorpos
RU2732295C1 (ru) * 2020-01-10 2020-09-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации Препарат для укрепления и стимулирования роста волос и способ его использования
CN116456981A (zh) * 2020-11-19 2023-07-18 辉瑞爱尔兰制药公司 用于改善的grp抑制剂递送的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2524310A2 (fr) * 1982-04-01 1983-10-07 Olivier Georges Compositions permettant de combattre les mefaits et les inconvenients de la transpiration
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
SE9201425D0 (sv) * 1992-05-06 1992-05-06 Kabi Pharmacia Ab Method and means for preventing constriction of the pupil in the eye
JPH08501553A (ja) * 1992-09-14 1996-02-20 スミス・ウォルター・ピー 皮膚調整組成物，その応用及び製造
US5420106A (en) * 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
US5543148A (en) * 1994-07-12 1996-08-06 Combe, Incorporated Stick delivery system for topical application of a treatment agent

Also Published As

Publication number Publication date
HU9600162D0 (en) 1996-03-28
EP0723774A1 (fr) 1996-07-31
PL312481A1 (en) 1996-08-05
PL184701B1 (pl) 2002-12-31
JP3043608B2 (ja) 2000-05-22
AR002023A1 (es) 1998-01-07
US6019967A (en) 2000-02-01
HUP9600162A3 (en) 1997-09-29
RU2180854C2 (ru) 2002-03-27
HUP9600162A2 (en) 1997-01-28
CA2167980C (fr) 2008-03-18
ES2154388T3 (es) 2001-04-01
FR2729855B1 (pt) 1997-02-21
DE69611106D1 (de) 2001-01-11
DE69611106T2 (de) 2001-04-05
EP0723774B1 (fr) 2000-12-06
DK0723774T3 (da) 2001-01-29
FR2729855A1 (fr) 1996-08-02
JPH08231434A (ja) 1996-09-10
ATE197896T1 (de) 2000-12-15
CA2167980A1 (fr) 1996-07-27

Similar Documents

Publication Publication Date Title
BR9600487A (pt) Utilização de ao menos um antagonistsa de cgrp utilização de ao menos um antagonista de cgrp em uma composição tópica processo de tratamento cosmético e composição
BR9601478A (pt) Utilizações de ao menos um antagonista de CGRP composição cosmética farmacêutica e/ou dermatológica processo de tratamento cosmético de vermilhidões cutâneas e processo de tratamento cosmético de rosásea e/ou de eritema pudico
BR9610375A (pt) Extrato de células composição cosmética ou farmacêutica utilização de pelo menos um extrato de células e processo de tratamento cosmético
BR9604010A (pt) Composição estável de aplicação tópica contendo o ácido ascórbico e pelo menos um poliol emusão uso em uma composição de aplicação tópica contendo o ácido ascórbico uso da composição processo de tratamento dosmético
BR9604031A (pt) Uso de pelo menos um composto escolhido de antagonistas de bradiquinina uso em uma composição tópica de pelo menos um composto escolhido de antagonistas de bradiquinha processo de tratamento cosmético e composição cosmética farmacêutica ou dermatológica
BR9500555A (pt) Composição cosméticas de uso tópico,processo de preparação de composições,utilização de composições e processo de tratamento cosmético
BR9800660A (pt) Emulsão água-em-óleo sua utilização composição cosmética e/ou dermatológica processo de tratamento cosmético e utilzação de uma associação
BR9504998A (pt) Composições cosméticas de uso tópico utilização de composições processo de tratamento cosmético e utilização de uma mistura
BR9610522A (pt) Composição para lavagem do corpo e processo para o tratamento da pele
BR9802120A (pt) Composição cosmética e/ou dermatológica composição dermatologica processo de tratamento cosmético utilização de uma composição processo de conservação de composições e utilização de um polímero poliaminado
BR9702662A (pt) Utilização do mel composição cosmética ou dermatiológica utilização cosmética da composição processo cosmético
BR9604089A (pt) Composição cosmética utilização de um copolímero acrílico e processo de tratamento cosmético de matérias ceratínicas
BR9407799A (pt) Composição de matéria método de tratamento e composição farmaceutica
BR9702541A (pt) Composição cosmética e/ou dermatológica utilização da composição e processo para tratamento não-terapêutico cosmético
BR9708362A (pt) Utilização de uma quantidade eficaz de um extrato e processo de tratamento cosmético
BR9705382A (pt) Emulsão óleo-em-água composição de uso tópico utilização de emulsão processo de tratamento não terapêutico e processo de preparação de emulsão
BR9608376A (pt) Utilização em cosméticos de uma composição sólida expandida composição de uso cosmético ou dermatológico processo de preparação de uma composição e utilização de composição
BR9702517A (pt) Utilização de polímero composição e processo
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
BR9702054A (pt) Composição cosmética processo de tratamento cosmético das matérias queratínicas e utilização da composição
BR9707623A (pt) Composição cosmética processo de tratamento cosmético das matérias queratínicas e utilização da composição
BR9609602A (pt) Composição cosmética anidra utilização da composição e processo de tratamento cosmético
BR9604011A (pt) Composição estável de aplicação tópica contendo o ácido ascórbico e pelo menos um poliol emulsão uso em uma composição de aplicação tópica contendo o ácido ascórbico uso da composição processo de tratamento cosmético
BR9600494A (pt) Composição cosmética não lavável e processo de tratamento cosmético não lavável de materiais queratínicos
PT767666E (pt) Metodos e composicoes uteis em profilaxia e em terapia de problemas relacionados com endotoxemia

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: COM BASE NO ACIMA EXPOSTO, CONCLUI-SE QUE O PRESENTE PEDIDO NAO APRESENTA ATIVIDADE INVENTIVA FRENTE AOS DOCUMENTOS CITADOS D1 E D2 E COM BASE NO ART. 8 EM COMBINACAO COM O ART. 13 DA LPI NO 9279/96, DEVE SER INDEFERIDO

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61Q 19/00 (2006.01), A61K 8/64 (2006.0